Textextraktion: pypdf | Seiten: 4
1 ORDER of the Court of Appeal of the Unified Patent Court issued on 19 August 2024 concerning an application pursuant to R.223 RoP (Application for suspensive effect) APPELLANTS / DEFENDANTS IN THE MAIN PROCEEDINGS BEFORE THE CFI 1. Sibio Technology Limited, Kowloon, Hong Kong 2. Umedwings Netherlands B.V., Rijswijk, The Netherlands hereinafter also referred to as “Sibio c.s. (in singular)” both represented by: Thomas Gniadek, Rechtsanwalt, Simmons & Simmons LLP, Munich, Germany RESPONDENT / CLAIMANT IN THE MAIN PROCEEDINGS BEFORE THE CFI Abbott Diabetes Care Inc., Alameda, California, USA, hereinafter also referred to as “Abbott” represented by: Eelco Bergsma, Attorney at law, Taylor Wessing, Eindhoven, the Netherlands LANGUAGE OF THE PROCEEDINGS English PATENT AT ISSUE EP 2 713 879 PANE ...